These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26583330)
41. Epidermal growth factor-mediated activation of the map kinase cascade results in altered expression and function of ABCG2 (BCRP). Meyer zu Schwabedissen HE; Grube M; Dreisbach A; Jedlitschky G; Meissner K; Linnemann K; Fusch C; Ritter CA; Völker U; Kroemer HK Drug Metab Dispos; 2006 Apr; 34(4):524-33. PubMed ID: 16415123 [TBL] [Abstract][Full Text] [Related]
42. [Targeted Sox4 gene-knock-down suppresses xenograft growth of Xuanwei female lung cancer cell line XWLC-05 cells in nude mice]. Zhou Y; Wang X; Chen Y; Huang Y; Liu X; Jin C; Chen X; Li J; Huang Y Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):11-6. PubMed ID: 24685080 [TBL] [Abstract][Full Text] [Related]
43. DownRegulated SOX4 Expression Suppresses Cell Proliferation, Migration, and Induces Apoptosis in Osteosarcoma In Vitro and In Vivo. Chen D; Hu C; Wen G; Yang Q; Zhang C; Yang H Calcif Tissue Int; 2018 Jan; 102(1):117-127. PubMed ID: 29038881 [TBL] [Abstract][Full Text] [Related]
44. Vatalanib sensitizes ABCB1 and ABCG2-overexpressing multidrug resistant colon cancer cells to chemotherapy under hypoxia. To KK; Poon DC; Wei Y; Wang F; Lin G; Fu LW Biochem Pharmacol; 2015 Sep; 97(1):27-37. PubMed ID: 26206183 [TBL] [Abstract][Full Text] [Related]
45. MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2). Ma MT; He M; Wang Y; Jiao XY; Zhao L; Bai XF; Yu ZJ; Wu HZ; Sun ML; Song ZG; Wei MJ Cancer Lett; 2013 Oct; 339(1):107-15. PubMed ID: 23879965 [TBL] [Abstract][Full Text] [Related]
46. ABCG2 downregulation in glioma stem cells enhances the therapeutic efficacy of demethoxycurcumin. Chen L; Shi L; Wang W; Zhou Y Oncotarget; 2017 Jun; 8(26):43237-43247. PubMed ID: 28591733 [TBL] [Abstract][Full Text] [Related]
47. NHERF1 Enhances Cisplatin Sensitivity in Human Cervical Cancer Cells. Tao T; Yang X; Qin Q; Shi W; Wang Q; Yang Y; He J Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085111 [TBL] [Abstract][Full Text] [Related]
48. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells. Xia J; Yu X; Song X; Li G; Mao X; Zhang Y Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427 [TBL] [Abstract][Full Text] [Related]
49. Correlation between the promoter methylation status of ATP-binding cassette sub-family G member 2 and drug sensitivity in colorectal cancer cell lines. Moon HH; Kim SH; Ku JL Oncol Rep; 2016 Jan; 35(1):298-306. PubMed ID: 26497773 [TBL] [Abstract][Full Text] [Related]
50. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells. Sato H; Siddig S; Uzu M; Suzuki S; Nomura Y; Kashiba T; Gushimiyagi K; Sekine Y; Uehara T; Arano Y; Yamaura K; Ueno K Eur J Pharmacol; 2015 Jan; 746():258-66. PubMed ID: 25455500 [TBL] [Abstract][Full Text] [Related]
51. ABCG2: determining its relevance in clinical drug resistance. Robey RW; Polgar O; Deeken J; To KW; Bates SE Cancer Metastasis Rev; 2007 Mar; 26(1):39-57. PubMed ID: 17323127 [TBL] [Abstract][Full Text] [Related]
52. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1 Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895 [TBL] [Abstract][Full Text] [Related]
53. SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo. Tsai CN; Yu SC; Lee CW; Pang JS; Wu CH; Lin SE; Chung YH; Tsai CL; Hsieh SY; Yu MC Oncogene; 2020 Jun; 39(24):4695-4710. PubMed ID: 32404985 [TBL] [Abstract][Full Text] [Related]
54. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer. Wang T; Liu Z; Shi F; Wang J Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938 [TBL] [Abstract][Full Text] [Related]
55. Expression of BAF57 in ovarian cancer cells and drug sensitivity. Yamaguchi T; Kurita T; Nishio K; Tsukada J; Hachisuga T; Morimoto Y; Iwai Y; Izumi H Cancer Sci; 2015 Apr; 106(4):359-66. PubMed ID: 25611552 [TBL] [Abstract][Full Text] [Related]
56. ABCG2 gene amplification and expression in esophageal cancer cells with acquired adriamycin resistance. Liu L; Zuo LF; Guo JW Mol Med Rep; 2014 Apr; 9(4):1299-304. PubMed ID: 24535197 [TBL] [Abstract][Full Text] [Related]
57. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling. Su J; Wu S; Tang W; Qian H; Zhou H; Guo T Mol Carcinog; 2016 Nov; 55(11):1822-1832. PubMed ID: 26513225 [TBL] [Abstract][Full Text] [Related]
58. The role of SRY-related HMG box transcription factor 4 (SOX4) in tumorigenesis and metastasis: friend or foe? Vervoort SJ; van Boxtel R; Coffer PJ Oncogene; 2013 Jul; 32(29):3397-409. PubMed ID: 23246969 [TBL] [Abstract][Full Text] [Related]
59. Downregulation of RhoB Inhibits Cervical Cancer Progression and Enhances Cisplatin Sensitivity. Wang W; Jia Y; Liu Y; Lv X; Guo L; Meng S; Wang C Genes (Basel); 2024 Sep; 15(9):. PubMed ID: 39336777 [TBL] [Abstract][Full Text] [Related]
60. Guanosine monophosphate synthase upregulation mediates cervical cancer progression by inhibiting the apoptosis of cervical cancer cells via the Stat3/P53 pathway. Wang J; Wu Y; Li Y; Wang Y; Shen F; Zhou J; Chen Y Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]